ORLOFF JOHN J 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Dec 18, 2020
Insider Transaction Report
Form 4
ORLOFF JOHN J
EVP, Research & Development
Transactions
- Tax Payment
Common Stock, par value $.0001 per share
2020-12-16$157.96/sh−18,134$2,864,447→ 67,072 total - Tax Payment
Common Stock, par value $.0001 per share
2020-12-16$157.96/sh−3,261$515,108→ 63,811 total - Award
Common Stock, par value $.0001 per share
2020-12-16+40,677→ 85,206 total - Award
Common Stock, par value $.0001 per share
2020-12-15$93.53/sh+40$3,741→ 63,851 total
Footnotes (4)
- [F1]Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan.
- [F2]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
- [F3]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- [F4]In accordance with the Alexion ESPP, these shares were purchased (for the ESPP purchase period from July 1, 2020 to December 15, 2020) based on 85% of the share price on July 1, 2020.